Scientific Program
Session 102: Cancer Genetics, Genomics and Epigenetics Time: 08:30-12:10, March 11, 2022 Time Speeches and Speakers Title: Targeting Cancer Stem-Like Cells in Diffuse Intrinsic Pontine Glioma Title: Telomere Homeostasis From Colorectal Adenoma to Metastatic Cancer
Chair
Call for Chair
08:30-08:35
Chair's Introduction
08:35-09:00
Title : Epigenetics of Developmental Tumors-Teratomas
Dr. Floriana Bulic-Jakus, University of Zagreb, Croatia
09:00-09:25
Title�� Towards a Novel Framework for Large Scale RNAseq Data Analysis in Human Health
Dr. Thérèse Commes, Groupe d'Études des Transcriptomes, Université Montpellier 2, France
09:25-09:50
Title : The Role of Genomic Structural Variants in Prognosis and Treatment of Cancer
Dr. James R. Broach Distinguished Professor and Chair, Penn State College of Medicine, USA
09:50-10:15
Title: Cooperation between Co-Amplified Genes in Hepatocellular Carcinoma (HCC)
Dr. Devanand Sarkar, Professor, Virginia Commonwealth University, USA
10:15-10:30
Coffee Break
10:30-10:55
Title: Pancreatic Neoplasm Associated with Pancreaticobiliary Maljunction - A Case Report and A Literature Review
Dr. Masako Ogawa, Ome Municipal General Hospital, Japan
10:55-11:20
Dr. Stefanie Galban, Assistant Professor, University of Michigan Medical School, USA
11:20-11:45
Title: TBD
Dr. Christine Gilles, Senior Research Associate, University of Liège, Belgium
11:45-12:10
Dr. Ludmila Vodickova, Institute of Experimental Medicine of the Czech Academy of Sciences, Czech Republic
| Session 202: Prognostic and Predictive Biomarkers | |
|
Time: 08:30-12:10, March 11, 2022 |
|
| Chair | Call for Chair |
|
Time |
Speeches and Speakers |
| 08:30-08:35 | Chair's Introduction |
| 08:35-09:00 | Title : Serum Soluble CD26/DPP4 Titer Variation Is A Potential Prognostic Biomarker In Cancer Therapy With A Humanized anti-CD26 antibody Dr. Yutaro Kaneko, Y’s AC Co., Ltd., Japan |
| 09:00-09:25 | Title: Using an Integrated Multiplexing Approach to Identify Prognostic Biomarkers in Rare Ovarian Granulosa Cell Tumors Dr. Anna Juncker-Jensen, PrincipalScientist,, NeoGenomics,USA |
| 09:25-09:50 | Title : Circular RNAs as Biomarkers and Therapeutic Targets in Cancer Dr. Valentin Pavlov, Professor, Rector of Bashkir State Medical University, Russia |
| 09:50-10:15 |
Title: TBD Dr. Yue Ge, Principla Investigator, National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency,USA |
| 10:15-10:30 | Coffee Break |
| 10:30-10:55 | Speech Opportunity Available |
| 10:55-11:20 | Title: TBD Dr. Janaina M. Ferreira, Professor, Universidade Nove de Julho (UNINOVE), Brazil |
| 11:20-11:45 | Title: TBD Dr. Livesey David Olerile, Shandong University, China |
| 11:45-12:10 | Title: TBD Dr. Marwa I. Abdelgawad, Lecturer, Assiut University, Egypt |
|
Session 302: Innovation and Biomarkers in Cancer Drug Development |
|
|
Time: 08:30-12:10, March 11, 2022 |
|
| Chair | Call for Chair |
|
Time |
Speeches and Speakers |
| 08:30-08:35 | Chair's Introduction |
| 08:35-09:00 | Title: TBD Dr. Dianqing (Dan) Wu, Gladys Phillips Crofoot Professor of Pharmacology, Yale School of Medicine, USA |
| 09:00-09:25 | Title: TBD Dr. Michael A Firer, Full Professor, Ariel University, Israel |
| 09:25-09:50 | Title: The Budget Impact of Monoclonal Antibodies Used to Treat Metastatic Colorectal Cancer in Minas Gerais, Brazil Dr. Wania Cristina da Silva, Federal University of Minas Gerais, Brazil |
| 09:50-10:15 | Speech Opportunity Available |
| 10:15-10:30 | Coffee Break |
| 10:30-10:55 |
Title Slimed Drug Discovery Process Can Deliver Promising Small Molecules that Can be Used to Turn Cold Immune Desert Tumors into hot Infiltrated Tumors which by that become Responsive to Immune Checkpoint Blockade |
| 10:55-11:20 | Title : Monitoring Anticoagulant Therapy and Its Associated Side Risks in Malignancy Dr. Amiral J, Scientific consultant, HYPHEN BioMed, France |
| 11:20-11:45 | Title: TBD Dr. Lenard M. Lichtenberger, Professor, The University of Texas Health Science Center at Houston, USA |
| 11:45-12:10 | Title: TBD Dr. Randa O. Kaddah, Director, LOGIC Consulting, Egypt |
|
Session 403: Lung Cancer/Other Thoracic Cancers |
|
|
Time: 08:30-12:10, March 11, 2022 |
|
| Chair | Call for Chair |
|
Time |
Speeches and Speakers |
| 08:30-08:35 | Chair's Introduction |
| 08:35-09:00 | Speech Opportunity Available |
| 09:00-09:25 | Title: TBD Dr. Evdokia Pasheva, Professor, Bulgarian Academy of Sciences, Bulgaria |
| 09:25-09:50 | Title: Immunohistochemical Profile of Control Cell Cycle, Proliferation and Differentiation Proteins of Atypical Epithelium with Diffuse Alveolar Damage Caused by COVID-19 in Comparison with Lepidic Adenocarcinoma Dr. Nikita Vladimirovich Boriskin, City Hospital ��40, Russia |
| 09:50-10:15 |
Title: Smoking Cessation Intervention Within the Framework of a Lung Cancer Screening Program: Preliminary Results and Clinical Perspectives from the “Cosmos-II |
| 10:15-10:30 | Coffee Break |
| 10:30-10:55 | Title : Mature TERATOMA in the Right Ventricle Dr. Fekede D Agwar, Cardiac Center of Ethiopia, Ethiopia |
| 10:55-11:20 | Title : Pulmonary lymphangioleiomyomatosis: A Proposed State of Neoplastic Senescence Dr. Charles Lombard, A Anatomic Pathology Specialist, , USA |
| 11:20-11:45 |
Title: Lung Cancer Screening by Single-Shot Dual-Energy Subtraction Using Flat-Panel Detector |
| 11:45-12:10 | Title: Tumor-suppressive Effects of microRNA-181d-5p on Non-Small-Cell Lung Cancer Dr. Shu-Feng Xu, the First Hospital of Qinhuangdao, China |
|
Session 404: Liver, Pancreatic an Biliary Tract Cancer |
|
|
Time: 08:30-12:10, March 11, 2022 |
|
| Chair | Dr. Junichi Arita, Associate Professor, University of Tokyo, Japan |
|
Time |
Speeches and Speakers |
| 08:30-08:35 | Chair's Introduction |
| 08:35-09:00 | Title: Hepatic Resections an Liver Transplantation: Signaling Pathways Involved in Protection Against Hepatic Ischemia-Reperfusion Damage and Liver Regeneration Failure and with Potential Tumorigenic Actions Dr. Carmen Peralta, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Spain |
| 09:00-09:25 |
Title : The Shanghai International Consensus on Diagnosis and Comprehensive TReatment of Colorectal Liver Metastases (2019) |
| 09:25-09:50 | Title: Acute Peritonitis Generalized by Typhoid Perforation at Friendship Hospital Sino Guinean of Kipe Dr. Soriba Narby Camara, Gamal Abdel Nasser University of Conakry, Guinea |
| 09:50-10:15 | Title: Repeat Resection of Neuroendocrine Liver Metastases And Possibility of Cure Dr. Junichi Arita, Associate Professor, University of Tokyo, Japan |
| 10:15-10:30 | Coffee Break |
| 10:30-10:55 | Title: Systemic Chemotherapy for Soft Tissue Sarcoma Rather than Liver, Pancreatic And Biliary Tract Cancer Dr. Hiroyuki Narahara, Director of Clinical Research Center, Hyogo Prefectural Nishinomiya Hospital, Japan |
| 10:55-11:20 | Title: TBD Dr. Rajesh Agarwal, Professor and Vice Chairman, Department of Pharmaceutical Sciences, University of Colorado Cancer Center, USA |
| 11:20-11:45 | Title : POSSIBILITIES OF IRREVERSABLE ELECTROPORATION IN TREATMENT OF LOCALLY ADVANCED PANCREATIC CANCER. WHERE IS THE PLACE Dr. Dmitry N. Panchenkov, Professor, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Russia |
| 11:45-12:10 |
Title: Impact of Viral Burden and Trajectory of Hepatocellular Carcinoma in Armenia |
| Session 502: Cancer Immunology & Immunotherapy | |
|
Time: 08:30-12:10, March 11, 2022 |
|
| Chair | Call for Chair |
|
Time |
Speeches and Speakers |
| 08:30-08:35 | Chair's Introduction |
| 08:35-09:00 | Speech Opportunity Available |
| 09:00-09:25 |
Title�� Rmored CAR T-Cells: The Next Chapter in CAR-T Cell Cancer Immunotherapy |
| 09:25-09:50 | Title: TBD Dr. Ramireddy Bommireddy, Instructor, Department of Pathology and Laboratory Medicine, Winship Cancer Institute of Emory University, USA |
| 09:50-10:15 | Title: Chimeric Antigen Receptors: Unleashing a New Age of Anti-Cancer Therapy Dr. Yan Leyfman, Penn State College of Medicine, USA |
| 10:15-10:30 | Coffee Break |
| 10:30-10:55 |
Title: New Perspectives to Improve the MHC-I Unrestricted Immune Mechanisms against Malignant Tumors |
| 10:55-11:20 | Title: TBD Dr. Soumaya Kilani-Jaziri, University of Monastir, Tunisia |
| 11:20-11:45 | Title: Rh3 Immunotherapy in Pediatric Brain Tumors Dr. Manuel Verdecia Jarque, Medical University of Granma, Cuba |
| 11:45-12:10 | Title: Individuality and Cancer Dr. Tamara Rubio Gonzalez, Medical University of Granma, Cuba |
|
Session 602: Pain Management and Clinical Complications |
|
|
Time: 08:30-12:10, March 11, 2022 |
|
| Chair | Call for Chair |
|
Time |
Speeches and Speakers |
| 08:30-08:35 | Chair's Introduction |
| 08:35-09:00 | Title: Acute Complications of Stem Cell Transplant, Immunotherapy and Oncology Treatment Dr. A. Guido Hita, Assistant Professor, University of Texas MD Anderson Cancer Center, USA |
| 09:00-09:25 | Title: The Development of TPN: An Ode to Staney Dudrick and Jonthan Rhoads. Edward Copeland Dr. Edward M. Copeland, Distinguished Professor Emeritus, University of Florida, USA |
| 09:25-09:50 | Title: The Strategy of Pain Management in Tunisia Based on the Population's Specificity Dr. Marwa Tlijani, Centre de maternité et de néonatologie de Monastir, Tunisie |
| 09:50-10:15 | Speech Opportunity Available |
| 10:15-10:30 | Coffee Break |
| 10:30-10:55 | Title: TBD Dr. Manohar Lal Sharma, The Walton Centre NHS Foundation Trust, Liverpool, UK |
| 10:55-11:20 | Title: TBD Dr. A Lee Dellon, Johns Hopkins University, USA |
| 11:20-11:45 | Title: TBD Dr. Amy Wachholtz, Assistant Professor, University of Massachusetts Medical School, USA |
| 11:45-12:10 | Title: TBD Dr. Misrak Woldeyohanes, Addis Ababa University, Ethiopia |
|
Session 103: Cancer Metabolism and Metabolic Pathways |
|
|
Time: 13:30-17:10, March 11, 2022 |
|
| Chair | Dr. Tomasz Brzozowski, Professor, Jagiellonian University Medical College, Poland |
|
Time |
Speeches and Speakers |
| 13:30-13:35 | Chair's Introduction |
| 13:35-14:00 | Speech Opportunity Available |
| 14:00-14:25 | Title : pH, Ion Transport in Connection with Metabolism and Invasion of Tumor Cells Dr. Laurent Counillon, Professor, Université Nice-Sophia Antipolis, France |
| 14:25-14:50 | Title: TBD Dr. Stephan J. Reshkin, Associate Professor, University of Bari, Italy |
| 14:50-15:15 | Title: TBD Dr. Catalina Carrasco Pozo, Research Fellow, Griffith University , Australia |
| 15:15-15:30 | Coffee Break |
| 15:30-15:55 | Title: TBD Dr. David Zangen, Associate Professor, Hadassah Hebrew University Medical Center, Israel |
| 15:55-16:20 | Title: Metabolic Plasticity in Ovarian Cancer Dr. Alia Ghoneum, Wake Forest University School of Medicine, USA |
| 16:20-16:45 | Speech Opportunity Available |
| 17:45-17:10 | Speech Opportunity Available |
|
Session 203: Next-Generation Cancer Imaging |
|
|
Time: 13:30-17:10, March 11, 2022 |
|
| Chair | Call for Chair |
|
Time |
Speeches and Speakers |
| 13:30-13:35 | Chair's Introduction |
| 13:35-14:00 |
Title: Nomogram-derived Prediction of Pathologic Complete Response (pCR) in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy (NCT) |
| 14:00-14:25 | Title: Affordable Diagnostics for In-Vivo Cancer Detection Dr. Pushpa Tandon, Program Director, National Cancer Institute, USA |
| 14:25-14:50 | Title : Targeting Glioblastoma (GBM) with a NIR-I Fluorescent Immunoconjugate for Facilitating Its Image-Guided Resection Dr. Kenneth S Hettie, Stanford University School of Medicine, USA |
| 14:50-15:15 | Title : Minimally Invasive Head and Neck Surgery Dr. Davud B. Sirjani, Associate Professor, Director of Salivary Program, Stanford Stanford University School of Medicine, USA |
| 15:15-15:30 | Coffee Break |
| 15:30-15:55 | Title: TBD Dr. Denise Aberle, Professor, UCLA Medical Center, USA |
| 15:55-16:20 | Title : Second Cancer Estimation Associated to the Imaging Procedures Associated to Radiotherapy Treatments of Primary Cancers Dr. B. Sánchez-Nieto, Instituto de Física, Pontificia Universidad Católica de Chile, Chile |
| 16:20-16:45 | Title : Imaging Nail tumors on MRI: How to Make Difference Dr. Sana Boudabbous, Geneva University Hospital, Switzerland |
| 17:45-17:10 | Title: TBD Dr. Pierre Bourgeois, Professor, Université Libre de Bruxelles, Belgium |
| 17:10-17:35 | Speech Opportunity Available |
|
Session 303: Next-Generation Epigenetic Drugs |
|
|
Time: 13:30-17:10, March 11, 2022 |
|
| Chair | Call for Chair |
|
Time |
Speeches and Speakers |
| 13:30-13:35 | Chair's Introduction |
| 13:35-14:00 | Speech Opportunity Available |
| 14:00-14:25 | Speech Opportunity Available |
| 14:25-14:50 | Speech Opportunity Available |
| 14:50-15:15 | Speech Opportunity Available |
| 15:15-15:30 | Coffee Break |
| 15:30-15:55 | Speech Opportunity Available |
| 15:55-16:20 | Speech Opportunity Available |
| 16:20-16:45 | Speech Opportunity Available |
| 17:45-17:10 | Speech Opportunity Available |
|
Session 405: Colorectal Cancer |
|
|
Time: 13:30-17:10, March 11, 2022 |
|
| Chair | Call for Chair |
|
Time |
Speeches and Speakers |
| 13:30-13:35 | Chair's Introduction |
| 13:35-14:00 | Title : The Impact of a Routine Extended Standard lymphadenectomy During Liver Surgery for CCC, HCC and Colorectal Liver Metastases Dr. Otto Kollmar, Professor, Clarunis University Center for Gastrointestinal and Liver Disease, St. Clara Hospital and University Hospital Basel, Switzerland |
| 14:00-14:25 | Title: Organ Preservation with Papillon technique for T1-T3 rectal cancer Dr. Jean-Pierre Gerard, Antoine Lacassagne Cancer Center, France |
| 14:25-14:50 | Title: Characterization of Gastrointestinal Cancer Syndromes Dr. Carol A. Durno, Associate Professor, The Hospital for Sick Children, Canada |
| 14:50-15:15 | Title: TBD Dr. J.M. Mullerat, Hospital General de l’Hospitalet, Spain |
| 15:15-15:30 | Coffee Break |
| 15:30-15:55 | Title: Diagnosis and Treatment of Colorectal Anastomosis Dr. Giovanni Milito, Asociate Professor, University of Rome Tor Vergata, Italy |
| 15:55-16:20 | Speech Opportunity Available |
| 16:20-16:45 | Title: TBD Dr. Edward David Siddens, Fiona Stanley Hospital, Australia |
| 17:45-17:10 | Title : Mir20a/106a-WTX Axis Regulates RhoGDIa/CDC42 Signaling and Colon Cancer Progression Dr. Qing-Ling Zhang, Guangdong Provincial People’s Hospital, China |
|
Session 406: Solid Tumor Brain Metastasis |
|
|
Time: 13:30-17:10, March 11, 2022 |
|
| Chair | Dr. Thierry Philip, President, Curie Institute, France |
|
Time |
Speeches and Speakers |
| 13:30-13:35 | Chair's Introduction |
| 13:35-14:00 | Title: Ablation Rate and Thyroglobulin Decrease after Low-Dose 131I in Differentiated Thyroid Carcinoma Post-Total Thyroidectomy Dr. Duong Duc Binh, Times City International Hospital, Vietnam |
| 14:00-14:25 | Title : Melanoma Brain Metastases Dr. Kari Jacobsen, Oslo University Hospital, Norway |
| 14:25-14:50 | Title: The Role of Quality Evaluation in the Comprehensive Cancer Infrastructure European Project Dr. Thierry Philip, President, Curie Institute, France |
| 14:50-15:15 | Title: TBD Dr. W. Thabet, Service d’ORL et de Chirurgie cervico-faciale, CHU Habib Bourguiba, Tunisie |
| 15:15-15:30 | Coffee Break |
| 15:30-15:55 | Title: TBD Dr. Andre Pires, Instituto Português de Oncologia do Porto Francisco Gentil, , Portugal |
| 15:55-16:20 | Title: TBD Dr. Michael Brant-Zawadzki, Senior Physician Executive, Hoag Hospital, USA |
| 16:20-16:45 | Title: DM-CHOC-PEN Plus Radiation for Brain Tumors Dr. Andrew H Rodgers, Dekk Teck, USA |
| 17:45-17:10 | Dr. Anupam Mishra, Professor and Chairman, King George's Medical University Lucknow (UP), India |
|
Session 503: Cancer& Stem Cell Therapy |
|
|
Time: 13:30-17:10, March 11, 2022 |
|
| Chair | Call for Chair |
|
Time |
Speeches and Speakers |
| 13:30-13:35 | Chair's Introduction |
| 13:35-14:00 | Speech Opportunity Available |
| 14:00-14:25 | Speech Opportunity Available |
| 14:25-14:50 | Speech Opportunity Available |
| 14:50-15:15 | Speech Opportunity Available |
| 15:15-15:30 | Coffee Break |
| 15:30-15:55 | Speech Opportunity Available |
| 15:55-16:20 | Speech Opportunity Available |
| 16:20-16:45 | Speech Opportunity Available |
| 17:45-17:10 | Speech Opportunity Available |
|
Session 504: Robotic & Surgical Therapy |
|
|
Time: 13:30-17:10, March 11, 2022 |
|
| Chair | Call for Chair |
|
Time |
Speeches and Speakers |
| 13:30-13:35 | Chair's Introduction |
| 13:35-14:00 | Title: Modern Concepts in Surgical Oncology Dr. Bhaskar N. Rao, Surgery Director, St. Jude Children’s Research Hospital Memphis, USA |
| 14:00-14:25 | Title: Komplikationen in der endokrinen Chirurgie Dr. Thomas Steinmuller, Professor, DRK Kliniken Berlin-Westend, Germany |
| 14:25-14:50 | Title : Medical Treatment of Interstitial Cystitis as requested Dr. Henry Lewi, Consultant Urological Surgeon, Ramsay Springfield Hospital, UK |
| 14:50-15:15 | Title : Prospective Comparative Study of Integrated Positron Emission Tomography-Computed Tomography Scan Compared With Remediastinoscopy in the Assessment of Residual Mediastinal Lymph Node Disease After Induction Chemotherapy for Mediastinoscopy-Proven Stage I Dr. De Leyn Chairman, University Hospitals Leuven, Belgium |
| 15:15-15:30 | Coffee Break |
| 15:30-15:55 | Title : Surgical Skill (Video) and Multicenter Research Progresses On Minimally Invasive Surgery of Hilar Cholangiocarcinoma Dr. Xiong Yongfu, Institute of Hepatobiliary-Pancreatic-Intestinal Diseases, Affiliated Hospital of North Sichuan Medical College, China |
| 15:55-16:20 | Title: Advanced Diagnostic Techniques for Lung Cancer Dr. Michael J. Simoff, Professor of Medicine, FTA Wayne State University School of Medicine, USA |
| 16:20-16:45 | Title: TBD Dr. Ananth Vijendren, Luton and Dunstable University Hospital, UK |
| 17:45-17:10 | Title: Superior Technology of Lung Cancer Surgery: Robotic Surgery Dr. Anil Gokce,Thoracic Surgeon, University of Health Sciences, Ankara City Hospital, Turkey |
Hosting Organization
Official Travel Agency
Media
Partners
Contact Us
Add: Life Science Innovation Center BLD 3-2, 43 Torch Road,
High Tech Park, Dalian, LN 116023, China
© 2003-2022 All rights reserved by BIT Congress
